Literature DB >> 16332728

Evaluation of a general practitioner with special interest service for dermatology: randomised controlled trial.

Chris Salisbury1, Alison Noble, Sue Horrocks, Zoe Crosby, Viv Harrison, Joanna Coast, David de Berker, Tim Peters.   

Abstract

OBJECTIVE: To assess the effectiveness, accessibility, and acceptability of a general practitioner with special interest service for skin problems compared with a hospital dermatology clinic.
DESIGN: Randomised controlled trial.
SETTING: General practitioner with special interest dermatology service and hospital dermatology clinic. PARTICIPANTS: Adults referred to a hospital dermatology clinic and assessed by a consultant or the general practitioner with special interest service,. Suitable patients had non-urgent skin problems and had been identified from the referral letter as suitable for management by a general practitioner with special interest.
INTERVENTIONS: Participants were randomised in 2:1 ratio to receive management by a general practitioner with special interest or usual hospital outpatient care. MAIN OUTCOME MEASURES: Primary outcomes were disease related quality of life (dermatology life quality index) and improvement in patients' perception of access to services, assessed nine months after randomisation. Secondary outcomes were patient satisfaction, preference for site of care, proportion of failed appointments, and waiting times to first appointment.
RESULTS: 49% of the participants were judged suitable for care by the general practitioner with special interest service. Of 768 patients eligible, 556 (72.4%) were randomised (354 to general practitioner with special interest, 202 to hospital outpatient care). After nine months, 422 (76%) were followed up. No noticeable differences were found between the groups in clinical outcome (median dermatology life quality index score = 1 both arms, ratio of geometric means 0.99, 95% confidence interval 0.85 to 1.15). The general practitioner with special interest service was more accessible (difference between means on access scale 14, 11 to 19) and waited a mean of 40 (35 to 46) days less. Patients expressed slightly greater satisfaction with consultations with a general practitioner with special interest (difference in mean satisfaction score 4, 1 to 7), and at baseline and after nine months 61% said they preferred care at the service.
CONCLUSIONS: The general practitioner with special interest service for dermatology was more accessible and preferred by patients than hospital outpatient care, achieving similar clinical outcomes. Trial registration ISRCTN31962758.

Entities:  

Mesh:

Year:  2005        PMID: 16332728      PMCID: PMC1315649          DOI: 10.1136/bmj.38670.494734.7C

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  7 in total

1.  General practitioners with special clinical interests: a cross-sectional survey.

Authors:  Roger Jones; Jenny Bartholomew
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 2.  Systematic review of outreach clinics in primary care in the UK.

Authors:  John Powell
Journal:  J Health Serv Res Policy       Date:  2002-07

3.  The role of UK general practitioners with special clinical interests: implications for policy and service delivery.

Authors:  Andrew Nocon; Brenda Leese
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

4.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

5.  Economic evaluation of a general practitioner with special interests led dermatology service in primary care.

Authors:  Joanna Coast; Sian Noble; Alison Noble; Sue Horrocks; Oya Asim; Tim J Peters; Chris Salisbury
Journal:  BMJ       Date:  2005-12-08

6.  A national evaluation of specialists' clinics in primary care settings.

Authors:  A Bowling; M Bond
Journal:  Br J Gen Pract       Date:  2001-04       Impact factor: 5.386

7.  Development of a questionnaire to assess patients' satisfaction with consultations in general practice.

Authors:  R Baker
Journal:  Br J Gen Pract       Date:  1990-12       Impact factor: 5.386

  7 in total
  30 in total

1.  General practitioners with special interests--not a cheap option.

Authors:  Martin Roland
Journal:  BMJ       Date:  2005-12-08

2.  Are GPs who specialise in dermatology effective? Result for teamwork and planning is positive.

Authors:  Stephen F Hayes
Journal:  BMJ       Date:  2006-01-07

3.  Are GPs who specialise in dermatology effective? Be wary of generalising research conclusions.

Authors:  Peter M Lapsley
Journal:  BMJ       Date:  2006-01-07

4.  Are GPs who specialise in dermatology effective? High cost of general practitioners with special interests is a fallacy.

Authors:  Cornelius J Crowley
Journal:  BMJ       Date:  2006-01-07

5.  Are GPs who specialise in dermatology effective? Cost calculations were impenetrable.

Authors:  Simon F Cooper
Journal:  BMJ       Date:  2006-01-07

Review 6.  Care closer to home: past mistakes, future opportunities.

Authors:  Minoo Irani; Michael Dixon; John D Dean
Journal:  J R Soc Med       Date:  2007-02       Impact factor: 5.344

Review 7.  Psoriasis and its management.

Authors:  Catherine H Smith; J N W N Barker
Journal:  BMJ       Date:  2006-08-19

8.  Who's kicking who?

Authors:  Nigel Hawkes
Journal:  BMJ       Date:  2006-09-23

9.  Dedicated general practitioner education sessions can improve diagnostic capabilities and may have a positive effect on referral patterns for common skin lesions.

Authors:  Suzanne M Beecher; Cillian Keogh; Claragh Healy
Journal:  Ir J Med Sci       Date:  2018-03-14       Impact factor: 1.568

10.  Clinical outcomes of an integrated primary-secondary model of care for individuals with complex type 2 diabetes: a non-inferiority randomised controlled trial.

Authors:  Anthony W Russell; Maria Donald; Samantha J Borg; Jianzhen Zhang; Letitia H Burridge; Robert S Ware; Nelufa Begum; H David McIntyre; Claire L Jackson
Journal:  Diabetologia       Date:  2018-10-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.